Stock Price
1,049.59
Daily Change
12.44 1.20%
Monthly
0.78%
Yearly
29.51%
Q1 Forecast
1,005.21

Eli Lilly reported $7.02 in EPS Earnings Per Share for its fiscal quarter ending in September of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q4 Dec/2025 7.16 5.32 Feb/04 2026
FY2025Q3 Sep/2025 7.02 6.36 1.18 Oct/30 2025
FY2025Q2 Jun/2025 6.31 5.55 3.92 Aug/07 2025
FY2025Q1 Mar/2025 3.34 4.71 2.58 May/01 2025
FY2024Q4 Dec/2024 5.32 5.30 2.49 Feb/06 2025




Eps Change Date
AbbVie USD 1.86 1.11 Sep/2025
Abbott USD 1.5 0.2 Dec/2025
ALKERMES USD 0.49 0.03 Sep/2025
Amgen USD 5.64 0.38 Sep/2025
AstraZeneca USD 2.38 0.21 Sep/2025
Baxter International USD 0.69 0.1 Sep/2025
Biogen USD 4.81 0.66 Sep/2025
Bristol-Myers Squibb USD 1.63 0.17 Sep/2025
Drreddys Laboratories INR 0.16 0.04 Dec/2025
Eli Lilly USD 7.02 0.71 Sep/2025
Gilead Sciences USD 2.47 0.46 Sep/2025
GlaxoSmithKline GBP 0.55 0.08 Sep/2025
Glaxosmithkline GBP 0.72 0.37 Sep/2025
J&J USD 2.46 0.34 Dec/2025
Medtronic USD 1.07 0.08 Sep/2025
Merck USD 2.58 0.45 Sep/2025
Neurocrine Biosciences USD 2.17 0.52 Sep/2025
Novartis USD 2.04 0.38 Sep/2025
Novartis USD 2.02 0.04 Sep/2025
Novo Nordisk DKK 5.96 0 Sep/2025
Perrigo USD 0.8 0.23 Sep/2025
Pfizer USD 0.87 0.09 Sep/2025
Prestige Brands USD 1.07 0.12 Sep/2025
Regeneron Pharmaceuticals USD 11.44 0.39 Dec/2025
Roche Holding CHF 8.37 2.95 Dec/2025
Sanofi EUR 1.53 1.38 Dec/2025
Sanofi EUR -0.67 3.62 Dec/2025
United Therapeutics USD 7.16 0.75 Sep/2025
Zoetis USD 1.7 0.06 Sep/2025